BUY MBP SOFOSBUVIR SOVALDI 400MG TAB 28TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Sofosbuvir is an antiviral medicine used to treat chronic hepatitis C virus infection. It belongs to a group of medicines called direct-acting antivirals and works by stopping the virus from multiplying inside the body. Sofosbuvir targets a specific viral enzyme known as NS5B RNA-dependent RNA polymerase, which the hepatitis C virus needs to replicate. By blocking this enzyme, sofosbuvir prevents the virus from making new copies of itself, allowing the body to clear the infection over time.

Sofosbuvir is not used alone. It is always given in combination with other antiviral medicines such as daclatasvir, ledipasvir, velpatasvir, or sometimes ribavirin, depending on the hepatitis C genotype, liver condition, and previous treatment history. When used correctly as part of combination therapy, sofosbuvir has very high cure rates, often exceeding 95 percent.

Sofosbuvir is taken by mouth, usually once daily, with or without food. It should be taken at the same time every day to maintain consistent drug levels in the body. The usual treatment duration is 12 weeks, but some patients may require 24 weeks depending on factors such as liver cirrhosis, previous treatment failure, or co-infection with other viruses.

Once treatment begins, the hepatitis C viral load usually drops rapidly, often becoming undetectable within a few weeks. Many patients notice improved energy levels and general wellbeing as treatment progresses. Even if symptoms improve early, it is essential to complete the full course of therapy to ensure complete viral eradication and prevent relapse.

Sofosbuvir is generally very well tolerated. The most commonly reported side effects include fatigue, headache, nausea, and mild insomnia. These side effects are usually mild and temporary. When sofosbuvir is taken together with ribavirin, additional side effects such as anaemia, shortness of breath, and weakness may occur, and closer monitoring is required.

Sofosbuvir has a good safety profile, but certain precautions are important. It should be used carefully in patients with severe kidney disease, as the drug and its metabolites are eliminated through the kidneys. Dose adjustment or alternative therapy may be needed in such cases. Liver function tests are usually monitored before and during treatment to ensure safety and effectiveness.

Sofosbuvir can interact with certain medicines that affect drug metabolism. Strong enzyme inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital, and St John?s wort can significantly reduce the effectiveness of sofosbuvir and must not be used together. It is important to inform the healthcare provider of all medications, supplements, or herbal products being taken.

In people co-infected with hepatitis B, reactivation of hepatitis B can occur during or after hepatitis C treatment. For this reason, screening for hepatitis B is required before starting sofosbuvir, and appropriate monitoring or treatment may be necessary.

Sofosbuvir should not be used during pregnancy unless clearly advised by a specialist. When combined with ribavirin, pregnancy must be strictly avoided due to the risk of severe birth defects. Effective contraception is required during treatment and for several months after completion if ribavirin is part of the regimen.

Sofosbuvir does not prevent transmission of hepatitis C during treatment. Patients should continue to practice measures that reduce the risk of transmission until cure is confirmed. Cure is defined as a sustained virologic response, meaning the virus remains undetectable in the blood 12 weeks after completing therapy.

When used correctly under medical supervision, sofosbuvir has transformed hepatitis C into a curable disease for most patients. It significantly reduces the risk of liver cirrhosis, liver failure, and liver cancer, and allows many people to return to normal, healthy lives after treatment completion.